Endobronchial metastases from extrathoracic malignancy

Sang Hoon Lee, Ji Ye Jung, Do Hoon Kim, Sang Kook Lee, Song Yee Kim, Eun Young Kim, Young Ae Kang, Moo Suk Park, Young Sam Kim, Joon Chang, Se Kyu Kim

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: Endobronchial metastasis is defined as documented extrathoracic malignancies metastatic to the endobronchus within a bronchoscopically visible range. Although the clinical and radiologic findings of endobronchial metastasis are similar to primary lung cancer, treatment and prognosis may be different. We hereby investigated the clinical, radiologic and bronchoscopic aspects of endobronchial metastases (EBM) in Korean patients. Materials and Methods: A total of 43 patients with EBM who underwent bronchoscopic biopsies from June 1991 to December 2009 at Severance Hospital, Yonsei University College of Medicine in Seoul, Korea, were analyzed retrospectively. We evaluated clinical, radiologic and bronchoscopic characteristics of EBM. Results: The patients consisted of 27 males and 16 females and their ages ranged from 18 to 77 years. The common primary cancers related to EBM were rectal (16.3%), colon (11.6%), breast (9.3%) and uterine (9.3%) cancers. The mean interval from diagnosis of primary cancer to EBM was 36 months, and the mean survival duration from diagnosis of EBM was 16.1 months in 33 deceased patients. Conclusion: EBM develop in various types of malignancies at various times with unremarkable manifestations. Therefore, physicians should consider the possibility of EBM, especially if a patient has a history of any malignancy, regardless of respiratory symptoms. Respiratory symptoms related with EBM can be treated by various safe procedures.

Original languageEnglish
Pages (from-to)403-409
Number of pages7
JournalYonsei medical journal
Volume54
Issue number2
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Neoplasm Metastasis
Neoplasms
Uterine Neoplasms
Korea
Lung Neoplasms
Colon
Breast
Medicine
Physicians
Biopsy
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, S. H., Jung, J. Y., Kim, D. H., Lee, S. K., Kim, S. Y., Kim, E. Y., ... Kim, S. K. (2013). Endobronchial metastases from extrathoracic malignancy. Yonsei medical journal, 54(2), 403-409. https://doi.org/10.3349/ymj.2013.54.2.403
Lee, Sang Hoon ; Jung, Ji Ye ; Kim, Do Hoon ; Lee, Sang Kook ; Kim, Song Yee ; Kim, Eun Young ; Kang, Young Ae ; Park, Moo Suk ; Kim, Young Sam ; Chang, Joon ; Kim, Se Kyu. / Endobronchial metastases from extrathoracic malignancy. In: Yonsei medical journal. 2013 ; Vol. 54, No. 2. pp. 403-409.
@article{552c3af4483c48b289db70571c2657fe,
title = "Endobronchial metastases from extrathoracic malignancy",
abstract = "Purpose: Endobronchial metastasis is defined as documented extrathoracic malignancies metastatic to the endobronchus within a bronchoscopically visible range. Although the clinical and radiologic findings of endobronchial metastasis are similar to primary lung cancer, treatment and prognosis may be different. We hereby investigated the clinical, radiologic and bronchoscopic aspects of endobronchial metastases (EBM) in Korean patients. Materials and Methods: A total of 43 patients with EBM who underwent bronchoscopic biopsies from June 1991 to December 2009 at Severance Hospital, Yonsei University College of Medicine in Seoul, Korea, were analyzed retrospectively. We evaluated clinical, radiologic and bronchoscopic characteristics of EBM. Results: The patients consisted of 27 males and 16 females and their ages ranged from 18 to 77 years. The common primary cancers related to EBM were rectal (16.3{\%}), colon (11.6{\%}), breast (9.3{\%}) and uterine (9.3{\%}) cancers. The mean interval from diagnosis of primary cancer to EBM was 36 months, and the mean survival duration from diagnosis of EBM was 16.1 months in 33 deceased patients. Conclusion: EBM develop in various types of malignancies at various times with unremarkable manifestations. Therefore, physicians should consider the possibility of EBM, especially if a patient has a history of any malignancy, regardless of respiratory symptoms. Respiratory symptoms related with EBM can be treated by various safe procedures.",
author = "Lee, {Sang Hoon} and Jung, {Ji Ye} and Kim, {Do Hoon} and Lee, {Sang Kook} and Kim, {Song Yee} and Kim, {Eun Young} and Kang, {Young Ae} and Park, {Moo Suk} and Kim, {Young Sam} and Joon Chang and Kim, {Se Kyu}",
year = "2013",
month = "3",
day = "1",
doi = "10.3349/ymj.2013.54.2.403",
language = "English",
volume = "54",
pages = "403--409",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "2",

}

Lee, SH, Jung, JY, Kim, DH, Lee, SK, Kim, SY, Kim, EY, Kang, YA, Park, MS, Kim, YS, Chang, J & Kim, SK 2013, 'Endobronchial metastases from extrathoracic malignancy', Yonsei medical journal, vol. 54, no. 2, pp. 403-409. https://doi.org/10.3349/ymj.2013.54.2.403

Endobronchial metastases from extrathoracic malignancy. / Lee, Sang Hoon; Jung, Ji Ye; Kim, Do Hoon; Lee, Sang Kook; Kim, Song Yee; Kim, Eun Young; Kang, Young Ae; Park, Moo Suk; Kim, Young Sam; Chang, Joon; Kim, Se Kyu.

In: Yonsei medical journal, Vol. 54, No. 2, 01.03.2013, p. 403-409.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endobronchial metastases from extrathoracic malignancy

AU - Lee, Sang Hoon

AU - Jung, Ji Ye

AU - Kim, Do Hoon

AU - Lee, Sang Kook

AU - Kim, Song Yee

AU - Kim, Eun Young

AU - Kang, Young Ae

AU - Park, Moo Suk

AU - Kim, Young Sam

AU - Chang, Joon

AU - Kim, Se Kyu

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Purpose: Endobronchial metastasis is defined as documented extrathoracic malignancies metastatic to the endobronchus within a bronchoscopically visible range. Although the clinical and radiologic findings of endobronchial metastasis are similar to primary lung cancer, treatment and prognosis may be different. We hereby investigated the clinical, radiologic and bronchoscopic aspects of endobronchial metastases (EBM) in Korean patients. Materials and Methods: A total of 43 patients with EBM who underwent bronchoscopic biopsies from June 1991 to December 2009 at Severance Hospital, Yonsei University College of Medicine in Seoul, Korea, were analyzed retrospectively. We evaluated clinical, radiologic and bronchoscopic characteristics of EBM. Results: The patients consisted of 27 males and 16 females and their ages ranged from 18 to 77 years. The common primary cancers related to EBM were rectal (16.3%), colon (11.6%), breast (9.3%) and uterine (9.3%) cancers. The mean interval from diagnosis of primary cancer to EBM was 36 months, and the mean survival duration from diagnosis of EBM was 16.1 months in 33 deceased patients. Conclusion: EBM develop in various types of malignancies at various times with unremarkable manifestations. Therefore, physicians should consider the possibility of EBM, especially if a patient has a history of any malignancy, regardless of respiratory symptoms. Respiratory symptoms related with EBM can be treated by various safe procedures.

AB - Purpose: Endobronchial metastasis is defined as documented extrathoracic malignancies metastatic to the endobronchus within a bronchoscopically visible range. Although the clinical and radiologic findings of endobronchial metastasis are similar to primary lung cancer, treatment and prognosis may be different. We hereby investigated the clinical, radiologic and bronchoscopic aspects of endobronchial metastases (EBM) in Korean patients. Materials and Methods: A total of 43 patients with EBM who underwent bronchoscopic biopsies from June 1991 to December 2009 at Severance Hospital, Yonsei University College of Medicine in Seoul, Korea, were analyzed retrospectively. We evaluated clinical, radiologic and bronchoscopic characteristics of EBM. Results: The patients consisted of 27 males and 16 females and their ages ranged from 18 to 77 years. The common primary cancers related to EBM were rectal (16.3%), colon (11.6%), breast (9.3%) and uterine (9.3%) cancers. The mean interval from diagnosis of primary cancer to EBM was 36 months, and the mean survival duration from diagnosis of EBM was 16.1 months in 33 deceased patients. Conclusion: EBM develop in various types of malignancies at various times with unremarkable manifestations. Therefore, physicians should consider the possibility of EBM, especially if a patient has a history of any malignancy, regardless of respiratory symptoms. Respiratory symptoms related with EBM can be treated by various safe procedures.

UR - http://www.scopus.com/inward/record.url?scp=84873243194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873243194&partnerID=8YFLogxK

U2 - 10.3349/ymj.2013.54.2.403

DO - 10.3349/ymj.2013.54.2.403

M3 - Article

C2 - 23364974

AN - SCOPUS:84873243194

VL - 54

SP - 403

EP - 409

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 2

ER -

Lee SH, Jung JY, Kim DH, Lee SK, Kim SY, Kim EY et al. Endobronchial metastases from extrathoracic malignancy. Yonsei medical journal. 2013 Mar 1;54(2):403-409. https://doi.org/10.3349/ymj.2013.54.2.403